Exploring alternative vaccine delivery systems could increase accessibility and encourage those who fear needles to receive ...
The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
"No one wants to lose their job. In the absence of any guidance, opinions fly about what we should do." -- An anonymous ...
Sen. Roger Marshall (R-Kan.) moved Wednesday to prohibit federal grants going toward all “dangerous” gain-of-function research on viruses, according to a copy of the ...
FILE - This colorized electron microscope image released by the National Institute of Allergy and Infectious Diseases on March ... epithelial cells (blue). (CDC/NIAID via AP, File) ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...
The announcement comes days after Dr Anthony Fauci, former National Institute of Allergy and Infectious Diseases Director ...